These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20001788

  • 1. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E, Reich E, Dotan S, Dransh P, Cohen I, Huszar M, Fogel M, Kleinman HK, White RM, Apte RN.
    J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
    [Abstract] [Full Text] [Related]

  • 2. Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells.
    Elkabets M, Krelin Y, Dotan S, Cerwenka A, Porgador A, Lichtenstein RG, White MR, Zoller M, Iwakura Y, Dinarello CA, Voronov E, Apte RN.
    J Immunol; 2009 Apr 15; 182(8):4874-81. PubMed ID: 19342666
    [Abstract] [Full Text] [Related]

  • 3. IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas.
    Apte RN, Douvdevani A, Huleihel M, Fima E, Hacham M, Shimoni N, Dvorkin T, Segal S.
    Folia Biol (Praha); 1992 Apr 15; 38(3-4):240-57. PubMed ID: 1426419
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
    Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA, Apte RN.
    Cancer Res; 2007 Feb 01; 67(3):1062-71. PubMed ID: 17283139
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 6. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
    Cahlin C, Körner A, Axelsson H, Wang W, Lundholm K, Svanberg E.
    Cancer Res; 2000 Oct 01; 60(19):5488-93. PubMed ID: 11034092
    [Abstract] [Full Text] [Related]

  • 7. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E, Weinstein Y, Benharroch D, Cagnano E, Ofir R, Dobkin M, White RM, Zoller M, Barak V, Segal S, Apte RN.
    Cancer Res; 1999 Mar 01; 59(5):1029-35. PubMed ID: 10070959
    [Abstract] [Full Text] [Related]

  • 8. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
    Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, Voronov E, Apte RN.
    J Immunol; 2011 Mar 15; 186(6):3462-71. PubMed ID: 21300825
    [Abstract] [Full Text] [Related]

  • 9. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM, Schreiber H, Ron Y.
    J Immunol; 1987 May 15; 138(10):3573-9. PubMed ID: 3571978
    [Abstract] [Full Text] [Related]

  • 10. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
    Chou T, Chang AE, Shu SY.
    J Immunol; 1988 Apr 01; 140(7):2453-61. PubMed ID: 2450925
    [Abstract] [Full Text] [Related]

  • 11. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ.
    Clin Cancer Res; 2002 Nov 01; 8(11):3561-9. PubMed ID: 12429647
    [Abstract] [Full Text] [Related]

  • 13. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN, Douvdevani A, Zoller M, White RM, Dvorkin T, Shimoni N, Huleihel M, Fima E, Hacham M, Voronov E.
    Folia Biol (Praha); 1994 Nov 01; 40(1-2):1-18. PubMed ID: 7958060
    [Abstract] [Full Text] [Related]

  • 14. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T, Sussman JJ, Krinock RA, Chang AE, Shu S.
    Cancer Res; 1994 May 15; 54(10):2744-50. PubMed ID: 8168105
    [Abstract] [Full Text] [Related]

  • 15. Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential.
    Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM.
    Cancer Res; 1992 Nov 01; 52(21):6020-4. PubMed ID: 1394227
    [Abstract] [Full Text] [Related]

  • 16. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
    Dvorkin T, Song X, Argov S, White RM, Zoller M, Segal S, Dinarello CA, Voronov E, Apte RN.
    J Leukoc Biol; 2006 Jul 01; 80(1):96-106. PubMed ID: 16707560
    [Abstract] [Full Text] [Related]

  • 17. [Current topics on tumor immunology].
    Tachibana T.
    Gan No Rinsho; 1983 Oct 01; 29(13):1492-8. PubMed ID: 6608013
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
    Zier KS, Salvadori S, Cronin KC, Gansbacher B.
    Cancer Gene Ther; 1994 Mar 01; 1(1):43-50. PubMed ID: 7621237
    [Abstract] [Full Text] [Related]

  • 19. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Mar 01; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 20. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.